Skip to main content
OpenTrials
Completed

NCT Number: NCT05312177

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous or planned CHD surgery.

Completed

Looking for future studies?

Notify Me

Key information

About this study

We are conducting a multicenter cohort study, ancillary to the Pediatric Heart Network (PHN) Residual Lesion Score (RLS) study, to investigate determinants of ND and behavioral outcomes in children with DS, focusing on the role of CHD surgery. We are including children with DS who had CAVSD repair, as this group comprises 91% of all children with DS in the RLS Study, with similar underlying congenital cardiac defect and surgical repair complexity, allowing our children with DS and CHD to be a homogeneous group. Moreover, one in five individuals with DS is born with an AVSD, a 2000 times higher incidence than in those with normal chromosomes. In addition to recruiting children with DS who had CAVSD repair, we will recruit similarly-aged children with DS who do not have documented major CHD (i.e., CHD requiring previous or planned CHD surgery) to come into the same PHN site for a single study visit consisting of detailed phenotyping by completion of a Health & Developmental History Intake form, ND and behavioral assessments, and optional collection and storage of saliva specimens in the PHN Biorepository. By building our sample from RLS Study participants and recruiting additional children who had infant CAVSD repair and meet study eligibility criteria, as well as a comparison group from the same PHN sites, we are leveraging rich prospective data in a group of DS children with CAVSD repair from a nationally representative sample, and the expertise of the PHN and Boston Children's Hospital (BCH).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Down Syndrome CAVSD Repair Group:

  • Trisomy 21
  • Male or Female, ages 5 years through 12 years
  • Had CAVSD repair within the first year of life
  • Parent or guardian and patient willing to comply with protocol and complete all study assessments; parent or guardian willing to provide written informed consent
  • Child able to speak and understand English

Down Syndrome Comparison Group

  • Trisomy 21
  • Male or Female, age 5 years through 12 years
  • No major CHD, defined as CHD requiring previous or planned CHD surgery
  • Parent or guardian and patient willing to comply with protocol and complete all study assessments; parent or guardian willing to provide written informed consent
  • Child able to speak and understand English

Exclusion criteria

Both Groups

  • Mosaic DS

Down Syndrome CAVSD Repair Group only - Did not have CAVSD repair in the first year of life

Down Syndrome Comparison Group only

  • Major CHD requiring previous or planned CHD surgery - i.e., CHD surgery occurring (a) in the period between birth and time of recruitment into the CHILD-DS Study, or (b) planned for a future date.

Treatment and study plan

Stanford Binet Intelligence Scales, Fifth Edition

Other

The SB-5 is a comprehensive measure of cognitive and intellectual functioning for individuals from age two through 85 years of age. The SB-5 individually assess a child's functioning in five areas of cognitive functioning: Fluid Reasoning, Knowledge, Quantitative Reasoning, Visual Spatial, and Working Memory. The SB-5 is well established in the existing research literature as an assessment tool to evaluate developmental and intellectual abilities in children with ND disorders.

Other names: SB-5

Vineland Adaptive Behavior Scales Third Edition

Other

The VABS-3 are a parent report, interview style measure of adaptive behavior for individuals ages birth through 90 months. The VABS-3 assesses adaptive behavior in four broad domains of Communication, Daily Living Skills, Socialization, and Motor Skills, and includes a Maladaptive Behavior Domain that assesses problem behaviors.

Other names: VABS-3

Peabody Picture Vocabulary Test, Fifth Edition

Other

The PPVT-5 is a norm-referenced language measure that evaluates single-word receptive vocabulary. The PPVT-5 provides standard scores for individuals ages 2.6 through 90 years.

Other names: PPVT-5

Expressive Vocabulary Test, Third Edition

Other

The EVT-3 is a norm-referenced language measure that evaluates single-word expressive vocabulary. The EVT-3 provides standard scores for individuals ages 2.6 through 90 years.

Other names: EVT-3

Leiter International Performance Scale, Third Edition

Other

The Leiter-3 is a nonverbal measure of cognitive functioning and fluid reasoning skills in individuals ages 3 through 75 years. The Leiter-3 measures nonverbal IQ across four subscales, including Sequential Order (SO), Form Completion (FC), Classification and Analogies (CA), and Figure Ground (FG).

Other names: Leiter-3

Social Communication Questionnaire, Current Form

Other

The SCQ is a parent-report measure of social communication, social interactions, play, and behavior.

Other names: SCQ

Aberrant Behavior Checklist

Other

The ABC-2 is a parent report measure of problematic behavior at home and in the community. It measures behavior on five subscales (1) Irritability, (2) Social Withdrawal, (3) Stereotypic Behavior, (4) Hyperactivity/Noncompliance, and (5) Inappropriate Speech.

Other names: ABC-2

Repetitive Behavior Scale, Revised

Other

The RBS-R is a parent report measure that comprehensively surveys for the presence of repetitive behaviors.

Other names: RBS-R

Primary outcomes

  1. Neurodevelopmental outcomes between children with DS who had CAVSD repair and children from the same clinical sites with DS without major CHD.

    Time frame: 1 day

    Verbal and non-verbal ratio intelligent quotients (IQs) derived from the Stanford Binet Intelligence Scales will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

  2. Behavioral outcomes between children with DS who had CAVSD repair and children from the same clinical sites with DS without major CHD.

    Time frame: 1 day

    Adaptive composite scores from the Vineland Adaptive Behavior Scales will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

  3. Language abilities compared between the children with DS and CAVSD repair and the children with DS without major CHD.

    Time frame: 1 day

    Using the Peabody Picture Vocabulary Test, Expressive Vocabulary Test, and Leiter International Performance Scale total language, auditory comprehension, and expressive communication will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

  4. Emotional outcomes compared between the children with DS and CAVSD repair and the children with DS without major CHD.

    Time frame: 1 day

    Using the Repetitive Behavior Scale and Aberrant Behavior Checklist , behavioral and emotional problems will be compared will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

  5. Social Communication compared between the children with DS and CAVSD repair and the children with DS without major CHD.

    Time frame: 1 day

    Using the Social Communication Questionnaire, social communication, social interactions, play and behavior will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

Secondary outcomes

  1. Comorbidities as predictors of neurodevelopment and behavior

    Time frame: 1 day

    Comorbidities will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

  2. Sociodemographic factors as predictors of neurodevelopment and behavior

    Time frame: 1 day

    Sociodemographic factors, such as will be compared between the children with DS and CAVSD repair and the children with DS without major CHD.

Sponsors and collaborators

Lead sponsor

Carelon Research

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institutes of Health (NIH)

Registry information

Acronym: CHILD-DS

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Apr 5, 2022
Registry last updated
Jan 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.